# Weyerhaeuser Co: Form 10-K for the period ended Dec 31, 2024

- Company: [Weyerhaeuser Co](/companies/wy.md) (CIK 106535)
- Form: 10-K
- Filed: 2025-02-14
- Accepted by EDGAR: Feb 14, 2025, 16:19 ET
- Period: 2024-12-31
- Accession: 0000950170-25-021254
- Inline XBRL: yes
- Main document: https://www.sec.gov/Archives/edgar/data/106535/000095017025021254/wy-20241231.htm
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/106535/000095017025021254/

## Figures reported in this filing

Standardized XBRL line items for the period ended 2024-12-31.

| Line item | Period | Value | XBRL concept |
| --- | --- | ---: | --- |
| Revenue | 12 months, 2024-01-01 to 2024-12-31 | $7.12bn | us-gaap:Revenues |
| Cost of revenue | 12 months, 2024-01-01 to 2024-12-31 | $5.81bn | us-gaap:CostOfGoodsAndServicesSold |
| Gross profit | 12 months, 2024-01-01 to 2024-12-31 | $1.31bn | us-gaap:GrossProfit |
| Research and development | 12 months, 2024-01-01 to 2024-12-31 | $7.0m | us-gaap:ResearchAndDevelopmentExpense |
| Operating income | 12 months, 2024-01-01 to 2024-12-31 | $685.0m | us-gaap:OperatingIncomeLoss |
| Interest expense | 12 months, 2024-01-01 to 2024-12-31 | $269.0m | us-gaap:InterestExpense |
| Income tax | 12 months, 2024-01-01 to 2024-12-31 | $31.0m | us-gaap:IncomeTaxExpenseBenefit |
| Net income | 12 months, 2024-01-01 to 2024-12-31 | $396.0m | us-gaap:NetIncomeLoss |
| Diluted EPS | 12 months, 2024-01-01 to 2024-12-31 | $0.54 | us-gaap:EarningsPerShareDiluted |
| Basic EPS | 12 months, 2024-01-01 to 2024-12-31 | $0.54 | us-gaap:EarningsPerShareBasic |
| Diluted shares (weighted) | 12 months, 2024-01-01 to 2024-12-31 | 728,957,000 shares | us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding |
| Operating cash flow | 12 months, 2024-01-01 to 2024-12-31 | $1.01bn | us-gaap:NetCashProvidedByUsedInOperatingActivities |
| Dividends paid | 12 months, 2024-01-01 to 2024-12-31 | $684.0m | us-gaap:PaymentsOfDividendsCommonStock |
| Share repurchases | 12 months, 2024-01-01 to 2024-12-31 | $154.0m | us-gaap:PaymentsForRepurchaseOfCommonStock |
| Cash and equivalents | at 2024-12-31 | $684.0m | us-gaap:CashAndCashEquivalentsAtCarryingValue |
| Current assets | at 2024-12-31 | $1.75bn | us-gaap:AssetsCurrent |
| Total assets | at 2024-12-31 | $16.54bn | us-gaap:Assets |
| Current liabilities | at 2024-12-31 | $977.0m | us-gaap:LiabilitiesCurrent |
| Total liabilities | at 2024-12-31 | $6.82bn | us-gaap:Liabilities |
| Long-term debt | at 2024-12-31 | $4.87bn | us-gaap:LongTermDebtNoncurrent |
| Current portion of debt | at 2024-12-31 | $210.0m | us-gaap:LongTermDebtCurrent |
| Shareholders' equity | at 2024-12-31 | $9.72bn | us-gaap:StockholdersEquity |

## Sections

No standard item headings were found in this filing’s main document, so no sections were extracted. Read the original on sec.gov. https://www.sec.gov/Archives/edgar/data/106535/000095017025021254/wy-20241231.htm

Filed Feb 14, 2025.
Source: SEC EDGAR, the filing index for accession 0000950170-25-021254. Last ingested by Listed: Nov 6, 2026, 03:40 ET. No prices; not investment advice.